Published in Blood Weekly, May 24th, 2007
The study also demonstrated PrepaCyte-CB's ability to remove approximately 99 percent of all unnecessary red blood cells (RBC) from final processed cord...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.